Investigation of the Underlying Mechanism of Huangqi-Dangshen for Myasthenia Gravis Treatment via Molecular Docking and Network Pharmacology

Table 6

Molecular docking results.

Compound	Target	PDB ID	Binding energy (kcal/mol)
Quercetin	EGFR	5ug9	−6.8
	CASP3	2dko	−6.6
	BIRC5	2qfa	−6.8
	AR	1t7r	−7.2
	VEGFA	3v2a	−6.3
	IL6	1alu	−6.4
	FOS	2wt7	−8.0
	MYC	6g6k	−6.3
Kaempferol	AR	1t7r	−7.6
	CASP3	2dko	−6.8
Luteolin	CASP3	2dko	−6.9
	BIRC5	2qfa	−7.3
	VEGFA	3v2a	−6.8
	AR	1t7r	−7.5
	EGFR	5ug9	−8.4
Isorhamnetin	ESR1	7baa	−7.2
	ESR2	3oll	−8.0
7-methoxy-2-methylisoflavone	ESR1	7baa	−7.1
	ESR2	3oll	−8.1